These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3144248)

  • 1. [Electrophysiological study of pro-arrhythmogenic effects of erythromycin].
    Ponsonnaille J; Citron B; Richard A; Trolese JF; Chaperon A; Barret B; Gras H
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1001-8. PubMed ID: 3144248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc-interval prolongation associated with slow intravenous erythromycin lactobionate infusions in critically ill patients: a prospective evaluation and review of the literature.
    Tschida SJ; Guay DR; Straka RJ; Hoey LL; Johanning R; Vance-Bryan K
    Pharmacotherapy; 1996; 16(4):663-74. PubMed ID: 8840374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Jet intravenous injection of erythromycin lactobionate. A possible cause of the occurrence of crisis in torsade de pointe].
    Camilleri JF; Deharo JC; Panagidès D; Broin P; Mésana T; Blin D; Mouly-Bandini A; Dubouloz C; Goudard A; Montiès JR
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(10):657-9. PubMed ID: 2698118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophysiologic effects of intravenous flecainide in intranodal junctional tachycardia in 30 patients].
    Haissaguerre M; Warin JF; Goldrach S; Le Métayer P; Guillem JP; Blanchot P
    Arch Mal Coeur Vaiss; 1988 Dec; 81(12):1493-8. PubMed ID: 3147639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [QT prolongation and induction of torsades de pointe by flecainide. Apropos of a case].
    Wickers F; Haissaguere M; Palussiere J
    Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1283-5. PubMed ID: 3146965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
    Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L
    Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophysiological effects of intravenous magnesium sulfate in man].
    Etienne Y; Blanc JJ; Grall JY; Boschat J; Gilard M; Houël JF; Penther P
    Arch Mal Coeur Vaiss; 1987 Aug; 80(9):1327-32. PubMed ID: 3122681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia.
    de Koning J; van der Hoeven H; Hamer B; Thompson J
    Neth J Med; 1994 Apr; 44(4):131-5. PubMed ID: 8196823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose.
    Buckley NA; Chevalier S; Leditschke IA; O'Connell DL; Leitch J; Pond SM
    Crit Care; 2003 Oct; 7(5):R101-7. PubMed ID: 12974977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac side effects of anti-arrhythmia agents].
    Seipel L
    Z Kardiol; 1988 Feb; 77(2):77-88. PubMed ID: 3284219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sick sinus syndrome with and without atrial fibrillation: atrial refractoriness and conduction characteristics.
    De Sisti A; Leclercq JF; Fiorello P; Di Lorenzo M; Manot S; Halimi F; Attuel P
    Cardiologia; 1999 Apr; 44(4):361-7. PubMed ID: 10371788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiologic effects of intravenous 3-hydroxy-dihydroquinidine (LNC-834) in man].
    Weissenburger J; le Heuzey JY; Clementy J; Ertzbischoff O; Coste P; Gutel B; Harley X; Jaillon P; Valty J; Cheymol G
    Arch Mal Coeur Vaiss; 1989 Dec; 82(12):2035-40. PubMed ID: 2515829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Mar; 146(10):451-60. PubMed ID: 15835343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac electrophysiologic effects of prostacyclin in man].
    Terrier de La Chaise A; Brembilla-Perrot B; Clozel JP; Cherrier F; Faivre G
    Arch Mal Coeur Vaiss; 1985 Aug; 78(8):1156-62. PubMed ID: 3935072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related cardiac electrophysiological effects of intravenous magnesium. A double-blind placebo-controlled dose-response study in patients with paroxysmal supraventricular tachycardia.
    Christiansen EH; Frost L; Andreasen F; Mortensen P; Thomsen PE; Pedersen AK
    Europace; 2000 Oct; 2(4):320-6. PubMed ID: 11194599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.